enCore Energy Corp. Securities Class Action Litigation

Introduction

Securities class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of enCore Energy Corp. (“enCore” or the “Company”) (NASDAQ: EU) between March 28, 2024 and March 2, 2025, inclusive (the “Class Period”).

If you purchased or acquired enCore securities during the Class Period, you may move the Court for appointment as lead plaintiff by no later than May 13, 2025.

A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the actions will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.

enCore investors who wish to learn more about the litigation and how to seek appointment as lead plaintiff should complete the form below, text or email investorinfo@lchb.com, or call Lieff Cabraser partner Sharon M. Lee at 1-800-541-7358.

Background on the enCore Securities Class Litigation

enCore, headquartered in Corpus Christi, Texas, acquires, explores, and develops uranium resource properties in the United States.

The action alleges that, throughout the Class Period, enCore and certain of its senior executives failed to disclose to investors that: (1) the Company lacked effective internal controls over financial reporting; (2) enCore could not capitalize certain exploratory and development costs under Generally Accepted Accounting Principles (“GAAP”); and (3) as a result, enCore’s net losses had sharply increased.

On May 3, 2025, enCore released disappointing fiscal 2024 financial results, revealing it had suffered a net loss of $61.3 million, more than twice its net loss in the previous fiscal year. The Company attributed the results to “the inability to capitalize certain exploratory and development costs under U.S. GAAP which would have been capitalized under [International Financial Reporting Standards].” enCore also disclosed that it had “identified in 2024” a material weakness in the Company’s internal controls over financial reporting due primarily to “an ineffective control environment that resulted in ineffective risk assessment, information, and communications and monitoring activities.” Additionally, enCore revealed it had appointed a new Chief Executive Officer “effective immediately” as Paul Goranson would no longer be serving as CEO and Director. On this news, enCore’s stock price declined $1.17 per share, or 46.43%, from its closing price of $2.52 per share on March 2, 2025, to close at $1.35 per share on March 3, 2025, on extremely heavy trading volume.